Petrus Trust Company’s Amphastar Pharmaceuticals AMPH Stock Holding History

Petrus Trust Company’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,013	Closed	-$243K	–	584
2024 Q3	$243K	Sell	5,013 -2,048	-29%	-$89.9K	0.02%	477
2024 Q2	$282K	Hold	7,061	–	–	0.03%	457
2024 Q1	$310K	Buy	7,061 +1,374	+24%	+$71K	0.03%	424
2023 Q4	$352K	Sell	5,687 -5,398	-49%	-$284K	0.03%	375
2023 Q3	$510K	Buy	11,085 +3,075	+38%	+$168K	0.05%	177
2023 Q2	$460K	Buy	+8,010	New	+$355K	0.05%	181

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Petrus Trust Company's AMPH Position: Q4 2024 in Review

Petrus Trust Company sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2024, closing a stake of 5,013 shares — an estimated $243K sold.

Petrus Trust Company first reported a position in AMPH in Q2 2023 and held it in 6 quarters. The position peaked at $510K in Q3 2023. 263 funds tracked by Wall St. Rank hold AMPH as of Q4 2024.

Petrus Trust Company reported no remaining Amphastar Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Petrus Trust Company sold 5,013 Amphastar Pharmaceuticals shares in Q4 2024, an estimated $243K.
Petrus Trust Company first reported a position in Amphastar Pharmaceuticals in Q2 2023 and held it in 6 quarters.
Petrus Trust Company's Amphastar Pharmaceuticals position peaked at $510K in Q3 2023.
263 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2024.

Based on Petrus Trust Company's 13F filing for Q4 2024, filed 14 Feb 2025.